Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that it is currently in production for the launch of a new and exclusive flavor to its Koios beverage lineup.
The Company has been working alongside its partners in the sports nutrition field to create a new and exclusive flavor, Strawberry Shortcake. As retail sales continue to increase each week due to the popularity of its current lineup, which include the Apricot Vanilla, Peach Mango, Berry Genius, Blood Orange, and Pear Guava beverages, the Company has decided to formulate a sixth new and exciting flavor.
“Strawberry Shortcake is a nostalgic throwback to summer desserts we enjoyed as kids,” said Chris Miller CEO of Koios. Adding further, “Working alongside our partners during the creative process gave us a more in-depth feel for consumer appeal. Collectively, we decided on Strawberry Shortcake, as this unique flavor profile has not yet hit shelves in a ready to drink format. We are incredibly excited to share this new flavor with our community of consumers and hope that everyone enjoys it just as much as we do!”
Koios beverages, in partnership with nationwide retailers are available in over 5,000 retail locations across the United States. Strawberry Shortcake will be exclusively available for a limited time at one of our nationwide retailer partners, before being released to all of our partner retailers throughout the country later this summer. We hope that the addition of this exclusive flavor will drive additional traffic to our retail partners and that our brand recognition will continue to increase within the sports nutrition community.
The Company has seen sales continue to increase each week since inception, and it has continued to receive additional purchase orders from GNC.
“The initial purchase orders we received from our nationwide retailer partners were considerable and we are encouraged to be receiving additional purchase orders in such quick turnaround time. Our online presence also continues to grow with our Instagram account reaching almost 40,000 followers, demonstrating that the Koios beverage lineup is becoming very popular. The additional purchase orders, plus increased weekly sales data and our social media presence proves that demand is strong as we set ourselves up for momentous growth,” said Chris Miller CEO of Koios.
On behalf of the Board of Directors of the Company.
KOIOS BEVERAGE CORP.
Chris Miller, CEO, and Director
About Koios Beverage Corp.
The Company is an emerging functional beverage company which has an available distribution network of more than 5,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including GNC, Walmart Inc., and Wishing-U-Well. Together these retailers represent over 50,000 brick and mortar locations across the United States from sports nutrition stores to large natural grocery chains. Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product.
Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing CBD market. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com.
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: statements with respect to the growth and size of the functional beverage and CBD infused beverage markets; statements with respect to our projected sales forecasts; statements with respect to our relationship with GNC to increase retail traffic; statements with respect to the perceived benefits that a new and exclusive flavor will bring to the Company; and statements regarding the business of the Company. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional and CBD infused beverage markets; (iii) consumer acceptance and adoption of functional beverages and CBD infused beverages as compared to other beverages; (v) changes which may affect the legalization of markets in the US and Canada; and (v) other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.
SOURCE Koios Beverage Corp.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2019/12/c9698.html
SOURCE: Koios Beverage Corp.
Gina Burrus, 844-255-6467, firstname.lastname@example.org